Advitech

Press releases

Advitech announces NPA approval of HYDRESIA ingredients

7 May 2010

QUEBEC CITY, QUEBEC - Advitech Inc. ("Advitech" ) (TSX Venture Exchange: AVI) today announces that it's subsidiary Botaneco Specialty Ingredients Inc. ("Botaneco" ) has received ingredient certification from the Natural Products Association (NPA) for Hydresia^TM SF2, Hydresia^TM G2, and Hydresia^TM Dulcé.  The NPA is North America's largest and oldest non-profit organization dedicated to the natural products industry. The association represents more than 10,000 retailers, manufacturers, wholesalers and distributors of natural products, including health and beauty aids.

"Botaneco is dedicated to manufacturing its products to comply with the highest natural production standards while eliminating the use of chemicals and synthetics," said Carl Cappabianca, Director of Sales and Marketing at Botaneco. "NPA certification further validates our product and production process with a highly recognized symbol for natural materials."

Hydresia^TM ingredients are encapsulation, delivery, and emulsification systems comprised of Oleosomes - naturally occurring oil reservoirs found in seeds. Using a proprietary non-solvent aqueous extraction process, Botaneco isolates Oleosomes from seed fully intact. Hydresia^TM ingredients are natural, renewable replacements for hydrocarbon derived and chemically modified materials and provide a variety of value added benefits including delivery, SPF boosting, and moisturization.

About Advitech

Advitech, which includes its subsidiary Botaneco Specialty Ingredients Inc. since November 20, 2009, is a health sciences and technology company developing, manufacturing and marketing proprietary natural ingredients and formulations for oral and topical applications that have been clinically proven to be safe and effective for improving skin health and well being. The Corporation's products are based on three technological platforms which are: i) a superior multi-functional emulsification delivery system derived from plant seed oleosomes for formulation application in the topical cosmetic, OTC, Rx and natural personal care specialty ingredient markets, ii) XP-828L for immune mediated inflammatory disorders, and iii) IM for anti-aging and wound healing. Advitech produces Hydresia^TM, a natural plant derived specialty ingredient which offers immediate moisturization advantages, formulating cost savings and excellent product aesthetics in a variety of product applications, Dermylex® for the treatment of mild-to-moderate psoriasis, and NudremylTM which acts on skin reconstruction, cellular regeneration and skin structure. More information is available and can be accessed at

www.advitech.com and http://www.botaneco.ca/.

This press release contains forward-looking statements, which reflect the Corporation's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein.  Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Michael Stangel, President and CEO

Advitech Inc.

418-948-4084

215-604-0631

info@advitech.com